carlisle & Associates
generic drug updates News contact carlisle medical
news
generic drug updates
Launch of Generic Androgel 1.62%
Released: 10/19/2018
By: Heidi Dufrene, PharmD

The generic equivalent of Androgel 1.62% (testosterone) has recently launched in the metered dose pump and unit-dose packets. Androgel is FDA-approved to treat hypogonadism, a condition in which there is a reduction or absence of endogenous sex hormones, such as testosterone. Androgel and other testosterone replacement products are often prescribed in workers’ compensation due to the decrease in testosterone levels in males from chronic opioid usage.


Generic prescription drugs approved by the FDA have the same high quality and strength as brand name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand name drugs.



If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com.

<<Back
 
Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2018 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer